亚宝药业：亚宝投资所持有的公司股份累计质押股份数为2685万股

Core Viewpoint - Yabao Pharmaceutical (SH 600351) announced that its controlling shareholder, Shanxi Yabao Investment Group, holds 94.3 million shares, accounting for 13.47% of the total share capital, with 26.85 million shares pledged, representing 28.47% of its holdings and 3.84% of the total share capital [1] Financial Performance - For the fiscal year 2024, Yabao Pharmaceutical's revenue composition is as follows: pharmaceutical manufacturing accounts for 75.46%, pharmaceutical wholesale for 21.37%, other trading for 1.88%, and other businesses for 1.29% [1] - As of the announcement date, Yabao Pharmaceutical has a market capitalization of 4.8 billion yuan [1]